Press "Enter" to skip to content

NIH ‘very concerned’ about serious side effect in AstraZeneca vaccine trial

The Food and Drug Administration is weighing whether to follow British regulators in resuming a coronavirus vaccine trial that was halted when a participant suffered spinal cord damage, even as the National Institutes of Health has launched an investigation of the case.

cnn topstories?d=yIl2AUoC8zA cnn topstories?d=7Q72WNTAKBA cnn topstories?i=ZrrL4Mofv3I:nq1Dl5CaXXE:V sGLiPBpWU cnn topstories?d=qj6IDK7rITs cnn topstories?i=ZrrL4Mofv3I:nq1Dl5CaXXE:gIN9vFwOqvQ

ZrrL4Mofv3I
The Food and Drug Administration is weighing whether to follow British regulators in resuming a coronavirus vaccine trial that was halted when a participant suffered spinal cord damage, even as the National Institutes of Health has launched an investigation of the case.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *